Design of Protective Headgear for Patients Who Have Undergone a Craniectomy

Sponsor
Tan Tock Seng Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05226741
Collaborator
(none)
5
1
1
3.6
1.4

Study Details

Study Description

Brief Summary

To design and create wearable head protection to be worn on a patient's head following a neurosurgical procedure (namely craniectomy and craniotomy

Condition or Disease Intervention/Treatment Phase
  • Device: Head protection device
N/A

Detailed Description

After being given informed consent, all participants will undergo the fitting and trial of a specially designed head protection for 6 weeks. Week 1 participants will be assessed and clinical data obtained on participants condition with the head protection fitted during the same session. Participants will return after 3 weeks for review and adjustment and again at the 6 week interval where they will also be given a questionnaire to fill up regarding their use and comfort.

Study Design

Study Type:
Interventional
Actual Enrollment :
5 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Design of Protective Headgear for Patients Who Have Undergone a Craniectomy
Actual Study Start Date :
Nov 11, 2021
Anticipated Primary Completion Date :
Mar 1, 2022
Anticipated Study Completion Date :
Mar 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Head protection

Participants are given a form of head protection

Device: Head protection device
The participants are fitted with a form of head protection over the craniectomy and provide feedback on design, use, and comfort

Outcome Measures

Primary Outcome Measures

  1. Patient Satisfaction Survey [6 weeks after receiving their head protection fitting]

    A survey to assess Satisfaction with device

Secondary Outcome Measures

  1. Euro Quality of Life - 5 Dimensions (EQ-5D) [6 weeks after receiving their head protection fitting]

    Quality of life survey. The higher the score from 0-5 for each dimension, the higher the quality of life.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subjects are eligible if they are 21 years or above and have had a DC >30 days, no wounds, able to understand simple commands and have a primary caregiver
Exclusion Criteria:
  • Exclusion criteria are patients with severe cognitive impairment, wounds, > unilateral DC, no caregiver

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tan Tock Seng Hospital Singapore Singapore 308433

Sponsors and Collaborators

  • Tan Tock Seng Hospital

Investigators

  • Principal Investigator: Trevor Binedell, Tan Tock Seng Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Tan Tock Seng Hospital
ClinicalTrials.gov Identifier:
NCT05226741
Other Study ID Numbers:
  • 2021/00540
First Posted:
Feb 7, 2022
Last Update Posted:
Feb 7, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tan Tock Seng Hospital

Study Results

No Results Posted as of Feb 7, 2022